Prognostic Significance of Postoperative Morbidities in Patients With Advanced Epithelial Ovarian Cancer Treated With Neoadjuvant Chemotherapy and Delayed Primary Surgical Debulking

By Le Tien   Alshaikh Ghadeer   Hopkins Laura   Faught Wylam   Fung Michael  

Annals of Surgical Oncology, Vol. 13, Iss. 12, 2006-12 ,pp. : 1711-1716

Springer Publishing Company

Access to resources Recommend Favorite

Progress in Survival Outcomes in Patients with Advanced Ovarian Cancer Treated by Neo-Adjuvant Platinum/Taxane-Based Chemotherapy and Late Interval Debulking Surgery

By Stoeckle Eberhard   Bourdarias Lionnel   Guyon Frédéric   Croce Sabrina   Brouste Véronique   Thomas Laurence   Floquet Anne  

Annals of Surgical Oncology, Vol. 21, Iss. 2, 2014-02 ,pp. : 629-636

Springer Publishing Company

Access to resources Recommend Favorite

Neoadjuvant Chemotherapy or Primary Debulking Surgery in Advanced Ovarian Carcinoma: A Retrospective Analysis of 285 Patients

By Vergote I.   De Wever I.   Tjalma W.   Van Gramberen M.   Decloedt J.   van Dam P.  

Gynecologic Oncology, Vol. 71, Iss. 3, 1998-12 ,pp. : 431-436

Elsevier

Access to resources Recommend Favorite

Plasma and tissue proteomic prognostic factors of response in primary breast cancer patients receiving neoadjuvant chemotherapy

By                

Oncology Reports, Vol. 29, Iss. 1, 2013-01 ,pp. : 355-361

Spandidos Publications

Access to resources Recommend Favorite

Neoadjuvant Chemotherapy for Advanced Ovarian Cancer

By Eisenkop S.M.   Spirtos N.M.   Friedman R.L.  

Gynecologic Oncology, Vol. 74, Iss. 2, 1999-08 ,pp. : 311-312

Elsevier

Access to resources Recommend Favorite